3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Neoplasms
4
Sarcoma
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Thymus Neoplasms
1
Sarcoma, Synovial
1
Prostatic Neoplasms
1
Multiple Myeloma
1
Mesothelioma
1
Meningioma
1
Melanoma
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Fatigue
1
Dermatofibrosarcoma
1
Cardiovascular Diseases
1
Carcinoma, Squamous Cell
1
Breast Neoplasms
1
Bone Neoplasms
1
Adenocarcinoma
1
Interventions
Specimen Handling
4
Gemcitabine
3
Doxorubicin
3
liposomal doxorubicin
2
Trabectedin
2
Magnetic Resonance Spectroscopy
2
Dacarbazine
2
Biopsy
2
toripalimab
1
regorafenib
1
peposertib
1
cemiplimab
1
anlotinib
1
abemaciclib
1
X-Rays
1
Tretinoin
1
Tissue Banks
1
Tablets
1
Surgical Procedures, Operative
1
Standard of Care
1
Rosuvastatin Calcium
1
Radiotherapy
1
Quality of Life
1
Nivolumab
1
Neoadjuvant Therapy
1
Midazolam
1
Injections
1
Immunoglobulin G
1
Ifosfamide
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Leiomyosarcoma
×
Quality of Life
×
Clear all
NCT07169344
2026-01-28
PROSARC-1
Oslo University Hospital
Phase 2
Recruiting
110 enrolled